Rentokil Initial

Quarterly Financials

Values in thousands 2024-12-31 2024-06-30 2023-12-31 2023-06-30
Revenue
$2,730,000
$2,706,000
$2,704,000
$2,671,000
Gross Profit
341,000
385,000
399,000
363,000
EBITDA
465,000
525,000
520,000
597,000
EBIT
310,000
360,000
399,000
363,000
Net Income
111,000
196,000
196,000
185,000
Net Change In Cash
2,730,000
2,706,000
2,704,000
2,671,000
Free Cash Flow
284,000
223,000
300,000
230,000
Cash
925,000
1,557,000
1,562,000
1,418,000
Basic Shares
2,526,000
2,530,000
2,527,000
2,527,000

Annual Financials

Values in thousands 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Revenue
$5,436,000
$5,375,000
$3,714,000
$2,953,900
Gross Profit
726,000
4,448,000
977,000
714,800
EBITDA
990,000
1,157,000
767,000
656,000
EBIT
670,000
682,000
381,000
329,500
Net Income
307,000
381,000
232,000
263,000
Net Change In Cash
5,436,000
5,375,000
3,714,000
2,953,900
Free Cash Flow
507,000
526,000
410,000
403,300
Cash
925,000
1,547,000
2,170,000
668,400
Basic Shares
2,528,000
2,527,000
2,014,000
1,866,300

Earnings Calls

Quarter EPS
2024-03-31
$0
2023-12-31
$0
2023-09-30
$0
2023-06-30
$0.72